Is NSC 145895 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use NSC 145895? Is NSC 145895 safe for nursing mother and child? Does NSC 145895 extracts into breast milk? Does NSC 145895 has any long term or short term side effects on infants? Can NSC 145895 influence milk supply or can NSC 145895 decrease milk supply in lactating mothers?
NSC 145895 lactation summary
- DrLact safety Score for NSC 145895 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of NSC 145895 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that NSC 145895 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of NSC 145895 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using NSC 145895 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About NSC 145895 usage in lactation
Colorante azoico con efecto analgésico en la mucosa del tracto urinario. Uno de sus metabolitos es el paracetamol. Puede teñir las secreciones corporales de color anaranjado. Riesgo de metahemoglobinemia. A fecha de última actualización no encontramos datos publicados sobre su excreción en leche materna. Producto de farmacocinética poco estudiada y de eficacia limitada. Hasta conocer más datos sobre este fármaco, son preferibles alternativas conocidas más seguras, en especial en el periodo neonatal y en caso de prematuridad o déficit de glucosa-6PD.
Answer by DrLact: About NSC 145895 usage in lactation
The safety of NSC 145895 is not established in infants or during breastfeeding. Because it can cause methemoglobinemia, sulfhemoglobinemia, and hemolytic anemia, it should be avoided while breastfeeding, especially with an infant under 1 month of age or with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Alternate Drugs
Phenazopyridine(Low Risk)